Panacea Biotec informs about press release

03 Jan 2017 Evaluate

Panacea Biotec has informed about a Press Release dated January 03, 2017 titled ‘Panacea Biotec Ensures Increased availability of Life Saving Drug Cilamin250 (D-Penicillamine IP 250mg) Capsules for Treatment of Wilsons disease in India’.

The above information is a part of company’s filings submitted to BSE.

Panacea Biotec Share Price

361.05 -23.65 (-6.15%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×